These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Approvable generic carbamazepine formulations may not be bioequivalent in target patient populations. Tothfalusi L; Endrenyi L Int J Clin Pharmacol Ther; 2013 Jun; 51(6):525-8. PubMed ID: 23611573 [TBL] [Abstract][Full Text] [Related]
5. Evaluating the bioavailability and bioequivalence of generic medications. Howland RH J Psychosoc Nurs Ment Health Serv; 2010 Jan; 48(1):13-6. PubMed ID: 20102127 [TBL] [Abstract][Full Text] [Related]
6. A multiple-dose safety and bioequivalence study of a narrow therapeutic index drug: a case for carbamazepine. Yacobi A; Zlotnick S; Colaizzi JL; Moros D; Masson E; Abolfathi Z; LeBel M; Mehta R; Golander Y; Levitt B Clin Pharmacol Ther; 1999 Apr; 65(4):389-94. PubMed ID: 10223775 [TBL] [Abstract][Full Text] [Related]
7. Generic versus brand name drugs in psychopharmacology: a pharmacoeconomic perspective. Emanuele E South Med J; 2011 Oct; 104(10):715-6. PubMed ID: 21941163 [No Abstract] [Full Text] [Related]
8. Bioequivalency revisited: epitol versus tegretol. Oles KS; Gal P Neurology; 1993 Dec; 43(12):2435-6. PubMed ID: 8255435 [No Abstract] [Full Text] [Related]
9. Criteria to assess in vivo performance and bioequivalence of generic controlled-release formulations of carbamazepine. Bialer M; Yacobi A; Moros D; Levitt B; Houle JM; Munsaka MS Epilepsia; 1998 May; 39(5):513-9. PubMed ID: 9596204 [TBL] [Abstract][Full Text] [Related]
10. Is generic prescribing acceptable in epilepsy? Besag FM Drug Saf; 2000 Sep; 23(3):173-82. PubMed ID: 11005701 [TBL] [Abstract][Full Text] [Related]
11. Bioequivalence of generic drugs in clinical psychopharmacology. Greenblatt DJ; Shader RI J Clin Psychopharmacol; 1987 Feb; 7(1):A21-3. PubMed ID: 3818990 [No Abstract] [Full Text] [Related]
12. A bioequivalence study on retarded formulations of carbamazepine tablets. Scheuch E; Hoffmann C; Franke G; Rabending G; Zschiesche M; Siegmund W Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):486-7. PubMed ID: 1490797 [No Abstract] [Full Text] [Related]
13. When is a "generic" medication not really a generic? Howland RH J Psychosoc Nurs Ment Health Serv; 2010 Feb; 48(2):13-6. PubMed ID: 20166651 [TBL] [Abstract][Full Text] [Related]
14. Reliability and risks of generic psychopharmacologic agents. Gelenberg AJ Essent Psychopharmacol; 2005; 6(6):348-55. PubMed ID: 16459758 [No Abstract] [Full Text] [Related]
15. Therapeutic bioequivalency study of brand name versus generic carbamazepine. Oles KS; Penry JK; Smith LD; Anderson RL; Dean JC; Riela AR Neurology; 1992 Jun; 42(6):1147-53. PubMed ID: 1603340 [TBL] [Abstract][Full Text] [Related]
16. Investigation of the bioequivalence of two carbamazepine sustained-release formulations in healthy subjects. Schulz HU; Düsing R; Lührmann B; Frercks HJ Int J Clin Pharmacol Ther Toxicol; 1992 Oct; 30(10):410-4. PubMed ID: 1446959 [TBL] [Abstract][Full Text] [Related]
17. Generic vs. branded carbamazepine. Aita JF Nebr Med J; 1988 Nov; 73(11):322-3. PubMed ID: 3200346 [No Abstract] [Full Text] [Related]
18. [Generics in psychiatry--do they have the same therapeutic equivalence as the original?]. Kasper S; Lentner S Neuropsychiatr; 2008; 22(4):221-2. PubMed ID: 19080992 [No Abstract] [Full Text] [Related]
19. Carbamazepine: a bioequivalence study and limited sampling modeling. Suarez-Kurtz G; Ribeiro FM; Salvadori MC; Struchiner CJ Int J Clin Pharmacol Ther; 2002 Sep; 40(9):424-30. PubMed ID: 12358160 [TBL] [Abstract][Full Text] [Related]
20. Medical and psychiatric implications of generic drugs. Diamond BI; Albrecht JW Psychopathology; 1987; 20 Suppl 1():92-8. PubMed ID: 3321135 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]